139 related articles for article (PubMed ID: 28185908)
21. AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis.
Kim DG; Choi Y; Lee Y; Lim S; Kong J; Song J; Roh Y; Harmalkar DS; Lee K; Goo JI; Cho HY; Mushtaq AU; Lee J; Park SH; Kim D; Min BS; Lee KY; Jeon YH; Lee S; Lee K; Kim S
Nat Commun; 2022 May; 13(1):2572. PubMed ID: 35546148
[TBL] [Abstract][Full Text] [Related]
22. Symmetric Assembly of a Decameric Subcomplex in Human Multi-tRNA Synthetase Complex Via Interactions between Glutathione Transferase-Homology Domains and Aspartyl-tRNA Synthetase.
Cho HY; Lee HJ; Choi YS; Kim DK; Jin KS; Kim S; Kang BS
J Mol Biol; 2019 Nov; 431(22):4475-4496. PubMed ID: 31473157
[TBL] [Abstract][Full Text] [Related]
23. Retractile lysyl-tRNA synthetase-AIMP2 assembly in the human multi-aminoacyl-tRNA synthetase complex.
Hei Z; Wu S; Liu Z; Wang J; Fang P
J Biol Chem; 2019 Mar; 294(13):4775-4783. PubMed ID: 30733335
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy.
Sivaraman A; Kim DG; Bhattarai D; Kim M; Lee HY; Lim S; Kong J; Goo JI; Shim S; Lee S; Suh YG; Choi Y; Kim S; Lee K
J Med Chem; 2020 May; 63(10):5139-5158. PubMed ID: 32315177
[TBL] [Abstract][Full Text] [Related]
25. Rapid detection of exon 2-deleted AIMP2 mutation as a potential biomarker for lung cancer by molecular beacons.
Jo SM; Kim Y; Jeong YS; Hee Oh Y; Park K; Kim HS
Biosens Bioelectron; 2013 Aug; 46():142-9. PubMed ID: 23537880
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug.
Lee B; Kim DG; Lee A; Kim YM; Cui L; Kim S; Choi I
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):51-66. PubMed ID: 36305287
[TBL] [Abstract][Full Text] [Related]
27. Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer.
Choi JW; Lee JW; Kim JK; Jeon HK; Choi JJ; Kim DG; Kim BG; Nam DH; Kim HJ; Yun SH; Kim S
J Mol Cell Biol; 2012 Jun; 4(3):164-73. PubMed ID: 22532625
[TBL] [Abstract][Full Text] [Related]
28. Reinvestigation of aminoacyl-tRNA synthetase core complex by affinity purification-mass spectrometry reveals TARSL2 as a potential member of the complex.
Kim K; Park SJ; Na S; Kim JS; Choi H; Kim YK; Paek E; Lee C
PLoS One; 2013; 8(12):e81734. PubMed ID: 24312579
[TBL] [Abstract][Full Text] [Related]
29. AIMP2 promotes TNFalpha-dependent apoptosis via ubiquitin-mediated degradation of TRAF2.
Choi JW; Kim DG; Park MC; Um JY; Han JM; Park SG; Choi EC; Kim S
J Cell Sci; 2009 Aug; 122(Pt 15):2710-5. PubMed ID: 19584093
[TBL] [Abstract][Full Text] [Related]
30. Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression.
Oh AY; Jung YS; Kim J; Lee JH; Cho JH; Chun HY; Park S; Park H; Lim S; Ha NC; Park JS; Park CS; Song GY; Park BJ
Cancer Res; 2016 Aug; 76(16):4791-804. PubMed ID: 27302160
[TBL] [Abstract][Full Text] [Related]
31. The DRS-AIMP2-EPRS subcomplex acts as a pivot in the multi-tRNA synthetase complex.
Hahn H; Park SH; Kim HJ; Kim S; Han BW
IUCrJ; 2019 Sep; 6(Pt 5):958-967. PubMed ID: 31576228
[TBL] [Abstract][Full Text] [Related]
32. Fluorescence-Based Analysis of Noncanonical Functions of Aminoacyl-tRNA Synthetase-Interacting Multifunctional Proteins (AIMPs) in Peripheral Nerves.
Kim M; Kim H; Kim D; Park C; Huh Y; Jung J; Chung HJ; Jeong NY
Materials (Basel); 2019 Apr; 12(7):. PubMed ID: 30939730
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Multi-tRNA Synthetase Complex by Multiple Reaction Monitoring Mass Spectrometry Coupled with Size Exclusion Chromatography.
Park SJ; Ahn HS; Kim JS; Lee C
PLoS One; 2015; 10(11):e0142253. PubMed ID: 26544075
[TBL] [Abstract][Full Text] [Related]
34. Is Methionyl-tRNA Synthetase Applicable as a Diagnostic Marker for Lung Cancer in Bronchial Ultrasound-Guided Brushing Cells?
Lee K; Oh M; Lee KS; Cha YJ; Chang YS
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679529
[TBL] [Abstract][Full Text] [Related]
35. Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis.
Choi JW; Um JY; Kundu JK; Surh YJ; Kim S
Carcinogenesis; 2009 Sep; 30(9):1638-44. PubMed ID: 19622630
[TBL] [Abstract][Full Text] [Related]
36. VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2.
Yun SP; Kim H; Ham S; Kwon SH; Lee GH; Shin JH; Lee SH; Ko HS; Lee Y
Cell Death Dis; 2017 Apr; 8(4):e2741. PubMed ID: 28383562
[TBL] [Abstract][Full Text] [Related]
37. Case Report: Mutation in AIMP2/P38, the Scaffold for the Multi-Trna Synthetase Complex, and Association With Progressive Neurodevelopmental Disorders.
Mazaheri M; Yavari M; Zare Marzouni H; Stufano A; Lovreglio P; S'Amore S; Jahantigh HR
Front Genet; 2022; 13():816987. PubMed ID: 35140751
[No Abstract] [Full Text] [Related]
38. Oncogenic Mutation of AIMP2/p38 Inhibits Its Tumor-Suppressive Interaction with Smurf2.
Kim DG; Lee JY; Lee JH; Cho HY; Kang BS; Jang SY; Kim MH; Guo M; Han JM; Kim SJ; Kim S
Cancer Res; 2016 Jun; 76(11):3422-36. PubMed ID: 27197155
[TBL] [Abstract][Full Text] [Related]
39. Aminoacyl-tRNA synthetase-interacting multifunctional proteins (AIMPs): a triad for cellular homeostasis.
Park SG; Choi EC; Kim S
IUBMB Life; 2010 Apr; 62(4):296-302. PubMed ID: 20306515
[TBL] [Abstract][Full Text] [Related]
40. Lentivirus-AIMP2-DX2 shRNA suppresses cell proliferation by regulating Akt1 signaling pathway in the lungs of AIMP2⁺/⁻ mice.
Hwang SK; Chang SH; Minai-Tehrani A; Kim YS; Cho MH
J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):165-73. PubMed ID: 23517169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
